Inhibition of Casein Kinase 2 induces cell death in chronic myelogenous leukemia cells resistant to tyrosine kinase inhibitors
O. Mitrovsky, D. Myslivcova, T. Machackova-Lopotova, A. Obr, K. Cermakova, S. Ransdorfova, J. Brezinova, H. Klamova, M. Zackova
This study shows that inhibiting Casein Kinase 2 (CK2) induces cell death in chronic myelogenous leukemia (CML) cells resistant to tyrosine kinase inhibitors (TKIs) and may enhance TKI efficacy.
bioRxiv · Jun 28, 2021Cancer Biology